A2cl Aurora Health Center - Good Hope Rd

CLIA Laboratory Citation Details

3
Total Citations
14
Total Deficiencyies
7
Unique D-Tags
CMS Certification Number 52D0390360
Address 3003 W Good Hope Rd, Milwaukee, WI, 53209
City Milwaukee
State WI
Zip Code53209
Phone(414) 352-3100

Citation History (3 surveys)

Survey - February 4, 2025

Survey Type: Standard

Survey Event ID: LK6411

Deficiency Tags: D6177 D6177

Summary:

Summary Statement of Deficiencies D6177 TESTING PERSONNEL RESPONSIBILITIES CFR(s): 493.1495(b)(3) (b)(3) Adhere to the laboratorys quality control policies, document all quality control activities, instrument and procedural calibrations and maintenance performed; This STANDARD is not met as evidenced by: Based on surveyor review of patient and maintenance logs and interview with the histotechnologist, staff A, testing personnel did not document room temperatures and humidity for six of seventeen patient testing days when staff B was the Mohs surgeon. Findings include: 1. Review of staff B's patient logs in 2024 showed patient testing days on: January 17 February 7, 21 March 6 April 3, 17 May 15 July 3, 17 August 7, 21 September 18 October 16 November 6, 20 December 4, 18 2. Review of the room temperature and humidity logs showed no documentation of temperatures or humidity on: April 17 July 18 October 16 November 20 December 4, 18 3. Interview with staff A on February 4, 2025, at 11:40 AM confirmed testing personnel did not document room temperature and humidity on each day of patient testing for Mohs surgery. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 1 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - April 17, 2023

Survey Type: Standard

Survey Event ID: FVTQ11

Deficiency Tags: D5413 D5429 D5439 D5413 D5429 D5439

Summary:

Summary Statement of Deficiencies D5413 TEST SYSTEMS, EQUIPMENT, INSTRUMENTS, REAGENT CFR(s): 493.1252(b) The laboratory must define criteria for those conditions that are essential for proper storage of reagents and specimens, accurate and reliable test system operation, and test result reporting. The criteria must be consistent with the manufacturer's instructions, if provided. These conditions must be monitored and documented and, if applicable, include the following: (1) Water quality. (2) Temperature. (3) Humidity. (4) Protection of equipment and instruments from fluctuations and interruptions in electrical current that adversely affect patient test results and test reports. This STANDARD is not met as evidenced by: Based on surveyor review of laboratory records, procedures, and manufacturer instructions and interview with the AP (Anatomic Pathology) Support Supervisor, the laboratory did not define room temperature or humidity requirements for the one of one dermatopathology laboratory room with histology equipment that were consistent with the Leica CM1950 cryostat manufacturer's instructions used in the laboratory. Findings include: 1. Review of maintenance records from the dermatopathology laboratory from the last 12 months showed the logs did not include acceptable humidity and temperature ranges for the dermatopathology laboratory. 2. Review of laboratory procedures showed no evidence of a defined temperature or humidity range for the dermatopathology laboratory. 3. Review of the manufacturer's instructions for the Leica CM1950 cryostat showed the manufacturer defined the acceptable room temperature as between 18 and 35 Celsius (C) with less than 60% relative humidity. 4. Interview with the AP support supervisor (staff C) on April 17, 2023 at 10:15 AM confirmed room temperature and humidity requirements consistent with the manufacturer's requirements had not been defined for the dermatopathology laboratory and confirmed testing personnel used a Leica CM1950 cryostat in the dermatopathology laboratory. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 3 -- D5429 MAINTENANCE AND FUNCTION CHECKS CFR(s): 493.1254(a)(1) For unmodified manufacturer's equipment, instruments, or test systems, the laboratory must perform and document maintenance as defined by the manufacturer and with at least the frequency specified by the manufacturer. This STANDARD is not met as evidenced by: Based on surveyor review of laboratory maintenance records and interview with the technical consultant, testing personnel did not perform and document one of four quarterly LED (light emitting diode) calibrations for the Sysmex CA coagulation analyzer in 2022. 1. Review of the monthly 'Sysmex CA 500/600 Maintenance Checklists' from 2022 showed testing personnel only documented quarterly LED calibrations in February, July, and October. 2. Interview with the technical consultant on April 17, 2023 at 3:15 PM confirmed the LED calibrations were not completed and documented quarterly in 2022 as required by the manufacturer. D5439 CALIBRATION AND CALIBRATION VERIFICATION CFR(s): 493.1255(b) Unless otherwise specified in this subpart, for each applicable test system the laboratory must do the following: Perform and document calibration verification procedure - (b)(1) Following the manufacturer's calibration verification instructions; (b)(2) Using the criteria verified or established by the laboratory under 493.1253(b)(3) -- (b)(2)(i) Including the number, type, and concentration of the materials, as well as acceptable limits for calibration verification; and (b)(2)(ii) Including at least a minimal (or zero) value, a mid-point value, and a maximum value near the upper limit of the range to verify the laboratory's reportable range of test results for the test system; and (b)(3) At least once every 6 months and whenever any of the following occur: (b)(3)(i) A complete change of reagents for a procedure is introduced, unless the laboratory can demonstrate that changing reagent lot numbers does not affect the range used to report patient test results, and control values are not adversely affected by reagent lot number changes. (b)(3)(ii) There is major preventive maintenance or replacement of critical parts that may influence test performance. (b)(3)(iii) Control materials reflect an unusual trend or shift, or are outside of the laboratory's acceptable limits, and other means of assessing and correcting unacceptable control values fail to identify and correct the problem. (b)(3)(iv) The laboratory's established schedule for verifying the reportable range for patient test results requires more frequent calibration verification. This STANDARD is not met as evidenced by: Item 1: Based on surveyor review of D-dimer calibration records, observation of reagents in the laboratory and interview with testing personnel, the laboratory has not performed a calibration or calibration verification of the D-dimer assay every six months since June 27, 2022. Findings include: 1. Review of D-dimer calibration records showed the last calibration or calibration verification was performed on June 27, 2022 with reagent lot 00875. Review of the 'Coagulation Calibration Curve Documentation' form showed the laboratory required calibration verification every six months if a new reagent lot calibration was not performed during that time. 2. Observation of the Sysmex CA analyzer on April 17, 2023 at 3:15 PM showed testing personnel were using lot 00875 for D-dimer testing at the time of the survey and -- 2 of 3 -- showed the last calibration testing personnel performed was on June 27, 2022. 3. Interview with testing personnel (staff B) on April 17, 2023 at 3:15 PM confirmed the D-dimer assay calibration verification was due in December 2022 and confirmed testing personnel had not performed a calibration or calibration verification since June 27, 2022. Item 2: Review of calibration verification records for the Dimension EXL analyzer and interview with testing personnel and the technical consultant revealed testing personnel had not performed calibration verification every six months as required for sodium, potassium and chloride electrolytes. Testing personnel had not performed three of the last four calibration verification events. Findings include: 1. Review of calibration verification records showed testing personnel performed calibration verification in March 2021 and March of 2022. No calibration verification records were available for September 2021, September 2022 or March 2023. 2. Interview with testing personnel (staff B) and the technical consultant (staff A) on April 17, 2023 at 3:10 PM confirmed testing personnel had not performed calibration verification on the Dimension EXL analyzer three of the last four times the calibration verification was due. This is a repeat deficiency previously cited on February 17, 2015. -- 3 of 3 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - June 21, 2021

Survey Type: Standard

Survey Event ID: QNIO11

Deficiency Tags: D5215 D6076 D6079 D5215 D6076 D6079

Summary:

Summary Statement of Deficiencies D5215 EVALUATION OF PROFICIENCY TESTING PERFORMANCE CFR(s): 493.1236(b)(2) The laboratory must verify the accuracy of any analyte, specialty or subspecialty assigned a proficiency testing score that does not reflect laboratory test performance (that is, when the proficiency testing program does not obtain the agreement required for scoring as specified in subpart I of this part, or the laboratory receives a zero score for nonparticipation, or late return or results). This STANDARD is not met as evidenced by: Based on surveyor review of proficiency testing (PT) records and interview with the technical consultant, the laboratory did not evaluate the accuracy for fifty-five of fifty- five "Not scored-insufficient peer group" "Hematolgy-Comprehensive-AF5" PT results for 2020 and 2021 and two of two "Not Graded" "Automated Urine Microscopy" PT results for 2020. Findings include: 1. Review of Wisconsin State Laboratory of Hygiene (WSLH) PT records showed the laboratory did not evaluate the accuracy of the following "Hematology-Comprehensive-AF5" PT results in 2020 and 2021. a. 2021-HemeReg1: Five of five "Not scored-insufficient peer group" "Leukocytes 10^9/L" results, five of five "Not scored-insufficient peer group" "Lymphocytes%" results, five of five "Not scored-insufficient peer group" "Basophil%" results and five of five "Not scored-insufficient peer group" "Hematocrit%" results. b. 2020-HemeReg1: Five of five "Not scored-insufficient peer group" "Monocytes%" results. c. 2020-HemeReg2: Five of five "Not scored- insufficient peer group" "Lymphocytes%" results, five of five "Not scored-insufficient peer group" "Basophils%" results and five of five "Not scored-insufficient peer group" Erythrocytes 10^12/L" results. d. 2020-HemeReg3: Five of five "Not scored- insufficient peer group" "Lymphocytes%" results, five of five "Not scored-insufficient peer group" "Basophils%" results and five of five "Not scored-insufficient peer group" Erythrocytes 10^12/L" results. 2. Review of American Proficiency Institute (API) PT records showed the laboratory did not evaluate the accuracy for two of two Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- "Not Graded" "Automated Urine Microscopy" results in 2020. 3. Interview with the technical consultant on June 8, 2021 at 10:35 AM confirmed the laboratory did not evaluate the accuracy for fifty-five of fifty-five "Not scored-insufficient peer group" "Hematolgy-Comprehensive-AF5" PT results for 2020 and 2021 and two of two "Not Graded" "Automated Urine Microscopy" PT results for 2020. D6076 LABORATORY DIRECTOR CFR(s): 493.1441 The laboratory must have a director who meets the qualification requirements of 493. 1443 of this subpart and provides overall management and direction in accordance with 493.1445 of this subpart. This CONDITION is not met as evidenced by: Based on surveyor review of the Laboratory Personnel Report (CLIA) form CMS-209 and laboratory records and interview and email with administrative laboratory director, Staff A, the laboratory director has not provided overall management and direction in accordance with 493.1445 of this subpart. Findings include: 1. The laboratory director did not provide overall management and direction for the histopathology testing in the laboratory. See D6079 D6079 LABORATORY DIRECTOR RESPONSIBILITIES CFR(s): 493.1445(a)(b) The laboratory director is responsible for the overall operation and administration of the laboratory, including the employment of personnel who are competent to perform test procedures, record and report test results promptly, accurately and proficiently, and for assuring compliance with the applicable regulations. (a) The laboratory director, if qualified, may perform the duties of the technical supervisor, clinical consultant, general supervisor, and testing personnel, or delegate these responsibilities to personnel meeting the qualifications under 493.1447, 493.1453, 493.1459, and 493.1487 respectively. (b) If the laboratory director reapportions performance of his or her responsibilities, he or she remains responsible for ensuring that all duties are properly performed. This STANDARD is not met as evidenced by: Based on surveyor review of previous survey records, Laboratory Personnel Report (CLIA) form CMS-209 and laboratory records and interview and email with administrative laboratory director, Staff A, the laboratory director has not provided overall management and direction for the histolopathology testing in the laboratory. Findings include: 1. Review of prior survey records from March 26, 2019 showed a histopathology specialty at this location. 2. Review of Laboratory Personnel Report (CLIA) form CMS-209 signed on June 4, 2021 showed no high complexity testing personnel, no technical supervisor and no general supervisor noted on the form for histopathology. 3. During the interview with Staff A on June 8, 2021 at 1:15 PM revealed the histopathology testing was no longer performed at this location. 4. Email from Staff A on June 11, 2021 at 1:57 PM confirmed that histolopathology testing was being performed at this location. 5. Interview with Staff A on June 21, 2021 at 9: 10 AM confirmed the laboratory director does have oversight of the histopathology testing at this location and has not provided overall management and direction of the histopathology testing in the laboratory. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access